Prepandemic Influenza Vaccine H5N1 (Split Virion, Inactivated, Adjuvanted) [Prepandrix™]: A Review of its Use as an Active Immunization Against Influenza A Subtype H5N1 Virus

Author： Carter Natalie J.   Plosker Greg L.  

Publisher： Adis International

ISSN： 1173-8804

Source： BioDrugs, Vol.22, Iss.5, 2008-01, pp. : 279-292

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A/H5N1 Prepandemic Influenza Vaccine (Vepacel®): A Guide to Its Use

By Keating Gillian M.   Plosker Greg L.   Lyseng-Williamson Katherine A.  

BioDrugs, Vol. 26, Iss. 6, 2012-12 ,pp. : 425-430

Adis International

Access to resources Recommend Favorite

New Strategies for the Development of H5N1 Subtype Influenza Vaccines: Progress and Challenges

By Steel John  

BioDrugs, Vol. 25, Iss. 5, 2011-10 ,pp. : 285-298

Adis International

Access to resources Recommend Favorite

Adjuvanted Influenza Vaccine

By Dooley M.   Goa K.L.  

BioDrugs, Vol. 14, Iss. 1, 2000-07 ,pp. : 61-69

Adis International

Access to resources Recommend Favorite

Efficacy of influenza vaccine in the elderly: reduction in risks of mortality and morbidity during an influenza A (H3N2) epidemic for the elderly in nursing homes

By Deguchi Y.  

International Journal of Clinical & Laboratory Research, Vol. 30, Iss. 1, 2000-03 ,pp. : 1-4

Springer Publishing Company

Access to resources Recommend Favorite

Adjuvanted Influenza Vaccine: A Viewpoint by R. Baltussen

By Baltussen R.  

BioDrugs, Vol. 14, Iss. 1, 2000-07 ,pp. : 70-71

Adis International

Access to resources Recommend Favorite